论文部分内容阅读
心律平是一种抗心律失常新药(Ⅰ_c类)。有较强的膜稳定作用,轻微的β阻滞作用,在体外有钙通道阻滞特性,尚具延长所有心肌组织动作电位时间的Ⅲ类药物特性,用于治疗室上性、室性心律失常。本文观察了30例不同类型心律失常患者,口服心律平的短期疗效和电生理作用。
Cardiac rhythm is a new anti-arrhythmic drug (Ⅰ_c class). Has a strong membrane stabilizing effect, a slight β block role in vitro with calcium channel block characteristics, still have to extend the action potential of all myocardial tissue class Ⅲ drug properties for the treatment of supraventricular and ventricular arrhythmias . In this paper, 30 patients with different types of arrhythmia were observed, short-term efficacy of oral rhythm and electrophysiological effects.